한국어 / ENG

SenoVue

SenoVue

SenoVue is a new groundbreaking medical device using multi-wavelength near-infrared technology.
It is currently in the clinical stage and is scheduled to be commercialized in 2024.

Breast Cancer Diagnostic Procedure

1. Region Selection 2. Scanning target areas 3. DICOM 1) Image Reading 4. PACS 2) Scan Result Reporting
1) DICOM(Digital Imaging and Communications in Medicine)
2) PACS: Picture Archiving and Communication
Clinical Studies
A new and safe measurement
SenoVue
Non-invasive and non-radioactive diagnosis

01

Technical excellence Technology to replace the existing mammoth market

02

High-Precision Biopsy-level diagnostic accuracy

03

Quantitative & Intuitive Malignancy index & Color image

04

Safe & Painless Non-radiative & non-invasive

05

Low Cost & Usability Low BOM(Bill of Materials)
Easy to install & Hospital's diverse usability

Purchase Consultation

SenoVue is a new groundbreaking medical device using multi-wavelength near-infrared technology.
It is currently in the clinical stage and is scheduled to be commercialized in 2025.

Breast Cancer Diagnostic Procedure

1. Region Selection
 
2. Scanning target areas
 
3. DICOM 1) Image Reading
 
4. PACS 2) Scan Result Reporting
1) DICOM(Digital Imaging and Communications in Medicine)
2) PACS: Picture Archiving and Communication
Clinical Studies
A new and safe measurement
SenoVue
Handheld Muscle Scanner and Tracker
for data-driven training

01

Technical excellence Technology to replace the existing mammoth market

02

High-Precision Biopsy-level diagnostic accuracy

03

Quantitative & Intuitive Malignancy index & Color image

04

Safe & Painless Non-radiative & non-invasive

05

Low Cost & Usability Low BOM(Bill of Materials) & Easy to install & Hospital's diverse usability

Purchase Consultation
TOP
TOP